Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06597370
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-11
Brief Title:
Immunogenicity Induced by COVID-19 Vaccines in Mexican Population
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Immunogenicity Induced by COVID-19 Vaccines in Mexican Population mRNA Expression for IgG Anti-spike
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Vaccines COVID
Brief Summary:
To determine the gene expression of anti-spike IgG through PCR-RT in patients vaccinated with the 4 types of vaccines available in Mexico OxfordAstraZeneca ChAdOx1 nCoV-19 Centro Nacional Gamaleya Sputnik V PfizerBioNTech BNT162b2 and Sinovac CoronaVac
Detailed Description:
80 subjects with full vaccination schedule will be included 20 per group To know the gene expression of IgG anti-spike through PCR-RT in patients vaccinated with the 4 types of vaccines available in Mexico OxfordAstraZeneca ChAdOx1 nCoV-19 Centro Nacional Gamaleya Sputnik V PfizerBioNTech BNT162b2 and Sinovac CoronaVac
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None